Thomas Gwydir's most recent trade in Nephros Inc was a trade of 27,613 Common Stock done . Disclosure was reported to the exchange on Jan. 5, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 27,613 | 43,226 (0%) | 0% | 0 | Common Stock | |
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,080 | 7,080 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 7,062 | 7,062 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 4,582 | 15,613 (0%) | 0% | 0 | Common Stock | |
| Nephros Inc | Thomas Gwydir | Director | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 18 Aug 2021 | 5,000 | 11,031 (0%) | 0% | 7.6 | 38,200 | Common Stock |
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 6,850 | 6,850 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 3,666 | 6,031 (0%) | 0% | 0 | Common Stock |